CollPlant Biotechnologies Ltd.
CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3Dā¦ read more
Healthcare
Biotechnology
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.27
Price-9.04%
-$0.03
1Y
Price
Market Cap
$3.537m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-3954.8%
EBITDA Margin-4242.5%
Net Profit Margin-4184.9%
Free Cash Flow Margin-3954.8%
EBITDA Margin-4242.5%
Net Profit Margin-4184.9%
Free Cash Flow MarginRevenue
$389k
-83.6%
1y CAGR+60.5%
3y CAGR+936.7%
5y CAGREarnings
-$13.134m
-14.3%
1y CAGR-40.0%
3y CAGR-15.4%
5y CAGREPS
-$1.03
-9.6%
1y CAGR-36.1%
3y CAGR-12.3%
5y CAGRBook Value
$4.886m
$9.183m
Assets$4.297m
Liabilities$2.649m
DebtDebt to Assets
28.9%
-0.2x
Debt to EBITDAFree Cash Flow
-$11.602m
-22.8%
1y CAGR-93.2%
3y CAGR-51.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company